Full-Time

Bioprocessing Associate III

Posted on 2/16/2023

Umoja Biopharma

Umoja Biopharma

51-200 employees

In vivo CAR T-cell gene therapy platform

AI & Machine Learning
Biotechnology

Compensation Overview

$30.9 - $41.8Hourly

Junior

Lafayette, CO, USA

Requirements
  • Associate's degree in a related life-science field, or equivalent in work experience
  • 1-2 years of cGMP manufacturing experience in the pharmaceutical and/or biologics field is desired or equivalent in work experience or education
  • Ability to gown aseptically and work in a Clean Room environment
  • Ability to work while gowned for extended periods of time
  • Extensive use of laboratory equipment includes handling chemicals and biological materials
  • Must have the ability to work around laboratories, manufacturing areas and equipment, and regularly lift 10-20 lbs. and periodically lift up to 50 lbs
  • Ability to work nights and weekends as needed
Responsibilities
  • Assist in the development and implementation of compliant and technically sound programs and systems in support of GMP manufacturing facility Operational Readiness
  • Actively participate in the receipt of internal technology transfer of novel cell/gene therapy manufacturing processes at various scales
  • Author and review-controlled documents and standard operating procedures on behalf of Manufacturing Operations
  • Observe, participate, and perform in aseptic process simulations and initial internal technology transfer runs from MSAT to Manufacturing
  • Perform activities related to the introduction of new raw materials, bulk drug substance, and drug product specifications from draft through approval
  • Perform equipment cleanings, as required, per routine maintenance events, pre/post process requirements, and initial facility commissioning
  • Adhere to Standard Operating Procedures, good manufacturing practices, and good documentation practices
  • Perform and participate in manufacturing equipment, process, and system validation activities including Environmental Monitoring Performance Qualification (EMPQ), and IQ/OQ/PQ (As applicable) of Manufacturing equipment and systems
  • Perform aseptic cell culture and manufacture of lentiviral products in an aseptic clean-room environment (ISO5, ISO7, ISO8, ISO9)
  • Maintain inventory and perform stocking activities for gowning, cleaning, and consumable materials to ensure sufficient inventory is available to support manufacturing operations
  • Perform material management activities related to the weigh/dispense and kitting of Bill of Materials items
  • Perform solution and buffer prep operations in a clean-room environment (ISO9)
  • Other duties as needed
Desired Qualifications
  • Prior experience receiving a technology transfer is strongly preferred
  • Prior GMP facility start-up experience is strongly preferred
  • Aseptic cell culture experience is strongly preferred
  • Prior MSAT experience is preferred
  • Downstream purification experience is strongly preferred (e.g., depth-filtration, tangential flow filtration, and/or chromatography)
  • Prior gene therapy or viral vector manufacturing experience preferred
  • Demonstrated experience working on results-oriented teams where contribution and collaboration were critical to project success
  • Proficient in computer applications such as word processing, spreadsheets, and web-based applications
  • Self-motivated with strong organization and communication skills and can work independently or as part of a multi-disciplinary matrixed team

Umoja Biopharma is a leader in the field of immuno-oncology, specifically focusing on in vivo reprogramming of T cells to target and eradicate cancer cells effectively. Their integrated platform therapeutics are pioneering advancements in the treatment of solid tumors and hematologic malignancies, enabling a new era of accessible and potent CAR T-cell therapies. The company's innovative approach, combined with a dedication to improving patient outcomes, makes it a compelling place to work for those interested in cutting-edge cancer treatment technologies and a culture of clinical excellence.

Company Stage

Series B

Total Funding

$271M

Headquarters

Seattle, Washington

Founded

2019

Growth & Insights
Headcount

6 month growth

9%

1 year growth

27%

2 year growth

43%
INACTIVE